{"id":69005,"date":"2026-03-13T11:51:26","date_gmt":"2026-03-13T11:51:26","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69005"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"cjc-1295-without-dac","status":"publish","type":"product","link":"https:\/\/medsbase.com\/fr\/product\/cjc-1295-without-dac\/","title":{"rendered":"CJC-1295 sans DAC"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u00e9ponse rapide \u2014 Qu'est-ce que le CJC-1295 sans DAC ?<\/h3>\n<p style=\"margin: 0;\"><strong>CJC-1295 sans DAC<\/strong> (\u00e9galement appel\u00e9 <strong>Mod GRF 1-29<\/strong>) est un analogue synth\u00e9tique modifi\u00e9 de GHRH (1-29) avec une demi-vie plasmatique courte d'environ 30 minutes. Contrairement \u00e0 la version DAC, il ne poss\u00e8de pas de lien de fixation \u00e0 l'albumine, produisant un <strong>profil pulsatile<\/strong> rather than sustained GH signal. This kinetic profile makes it the preferred tool when pulse-timing matters. Supplied in 2\u00a0mg to 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce que vous obtenez avec MedsBase :<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/fr\/reviews\/\">avis clients<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Chaque commande est couverte par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\"><strong>Politique de R\u00e9exp\u00e9ditions Garanties<\/strong><\/a> \u2014 si votre colis n'arrive pas dans les 20 jours ouvrables, nous le r\u00e9exp\u00e9dions.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Sp\u00e9cification<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">D\u00e9tail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u00e9ro CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">863288-34-0 (parent) \u00b7 446262-90-4 (forme Mod-GRF 1\u201329 largement cit\u00e9e)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formule mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>152<\/sub>H<sub>252<\/sub>N<sub>44<\/sub>O<sub>42<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">3367.92 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>S\u00e9quence<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">D-Ala-Tyr-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH<sub>2<\/sub> (Mod-GRF 1\u201329, sans lien DAC)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forme<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Poudre lyophilis\u00e9e (ou tel que fourni)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puret\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599 % (v\u00e9rifi\u00e9 par HPLC, COA sur demande)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Stockage<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilis\u00e9 : 2\u20138 \u00b0C (r\u00e9frig\u00e9rateur) pour le stock de travail ; \u221220 \u00b0C pour le stockage \u00e0 long terme des flacons non ouverts. Reconstitu\u00e9 : 2\u20138 \u00b0C, \u00e0 utiliser dans ~30 jours. Prot\u00e9ger de la lumi\u00e8re. Ne pas congeler-d\u00e9congeler la solution reconstitu\u00e9e.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Eau bact\u00e9riostatique (recommand\u00e9e) ou eau st\u00e9rile pour des fen\u00eatres d'utilisation plus courtes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Qu'est-ce que le CJC-1295 sans DAC ?<\/h2>\n<p><strong>CJC-1295 sans DAC<\/strong> (commun\u00e9ment appel\u00e9 <strong>Mod GRF 1-29<\/strong> ou simplement <strong>GRF 1-29 t\u00e9tra-substitu\u00e9<\/strong>) est un analogue synth\u00e9tique \u00e0 30 acides amin\u00e9s de l'hormone de lib\u00e9ration de l'hormone de croissance. Il partage la m\u00eame s\u00e9quence peptidique centrale que <a href=\"https:\/\/medsbase.com\/fr\/cjc-1295-with-dac\/\">CJC-1295 avec DAC<\/a> \u2014 quatre substitutions d'acides amin\u00e9s sur la s\u00e9quence native de GHRH (1-29) conf\u00e8rent une r\u00e9sistance \u00e0 la clivage par la DPP-IV \u2014 mais <strong>ne poss\u00e8de pas la modification DAC de liaison \u00e0 l'albumine<\/strong> that extends half-life in the &#8220;with DAC&#8221; version. The practical consequence of no DAC: plasma half-life remains in the minutes-to-hours range (~30 minutes) rather than days. Study protocols therefore use multiple daily injections (typically 2\u20133x) to maintain GHRH signal rather than the weekly dosing of the DAC version. This mimics the short, pulsatile profile of endogenous GHRH and is the preferred tool when pulse-timing matters \u2014 particularly in protocols studying physiological GH pulsatility alongside ghrelin-receptor agonists such as <a href=\"https:\/\/medsbase.com\/fr\/ipamorelin\/\">ipamorelin<\/a>. Molecular weight approximately 3,367\u00a0Da. Supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For mechanism, context, and stacking protocols, see our <a href=\"https:\/\/medsbase.com\/fr\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin &amp; CJC-1295 guide<\/a>. <\/p>\n<h2>M\u00e9canisme d'action \u2014 Signalisation pulsatile de la GHRH<\/h2>\n<p>Le Mod GRF 1-29 agit via la m\u00eame voie des r\u00e9cepteurs GHRH hypophysaires que la GHRH native, mais avec un profil cin\u00e9tique qui le distingue \u00e0 la fois de la GHRH native et de la version DAC :<\/p>\n<ul>\n<li><strong>Agonisme des r\u00e9cepteurs GHRH<\/strong> \u2014 Le CJC-1295 sans DAC se lie aux r\u00e9cepteurs GHRH des somatotropes hypophysaires, stimulant la synth\u00e8se et la lib\u00e9ration de l'hormone de croissance. Les substitutions d'acides amin\u00e9s r\u00e9sistent \u00e0 la d\u00e9gradation par la DPP-IV, conf\u00e9rant une activit\u00e9 plus longue que la GHRH native (qui ne dure que quelques minutes) mais toujours dans la fourchette de demi-vie courte de 30 minutes.<\/li>\n<li><strong>Cin\u00e9tique pulsatile courte<\/strong> \u2014 comme il n'y a pas d'ancrage \u00e0 l'albumine, les taux plasmatiques augmentent et diminuent sur une \u00e9chelle de temps correspondant \u00e0 l'architecture naturelle des pulses de GH de l'organisme. C'est la distinction m\u00e9caniste critique par rapport \u00e0 la version DAC, qui produit une \u00e9l\u00e9vation soutenue non pulsatile.<\/li>\n<li><strong>Synergie avec les GHRP via un r\u00e9cepteur parall\u00e8le<\/strong> \u2014 la co-administration avec un peptide de lib\u00e9ration de l'hormone de croissance tel que <a href=\"https:\/\/medsbase.com\/fr\/ipamorelin\/\">ipamorelin<\/a> (acting on the parallel ghrelin-receptor pathway) produces GH pulses substantially larger than either compound alone. The short-half-life version is often preferred for this stacking studies because both peptides can be timed together for same-pulse amplification.<\/li>\n<\/ul>\n<p>The studies implication: Mod GRF 1-29 is the tool of choice when the studies question involves <em>signalisation physiologique pulsatile de la GH<\/em>. La version DAC est pr\u00e9f\u00e9r\u00e9e lorsque la question implique <em>une \u00e9l\u00e9vation soutenue de la GH\/IGF-1<\/em>. M\u00eame famille de peptides ; pharmacocin\u00e9tique fondamentalement diff\u00e9rente. <\/p>\n<h2>Published Evidence<\/h2>\n<p>CJC-1295 without DAC is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Lib\u00e9ration pulsatile de GH<\/strong> \u2014 physiological GH-pulse support matching native GHRH kinetics<\/li>\n<li><strong>empilement d'Ipamorelin<\/strong> \u2014 the canonical GHRH + GHRP studies combination, often using the short-half-life variant for same-pulse timing<\/li>\n<li><strong>Body composition studies<\/strong> \u2014 lean-mass, IGF-1 response, and body-composition studies in pulsatile GH-axis modulation studies<\/li>\n<li><strong>Architecture du sommeil<\/strong> \u2014 pre-sleep dosing aligned with endogenous nocturnal GH-surge studies<\/li>\n<li><strong>Recovery studies<\/strong> \u2014 protocoles de r\u00e9cup\u00e9ration du muscle squelettique combin\u00e9s avec <a href=\"https:\/\/medsbase.com\/fr\/bpc-157\/\">BPC-157<\/a> et <a href=\"https:\/\/medsbase.com\/fr\/tb-500\/\">TB-500<\/a> for connective-tissue and muscle studies<\/li>\n<li><strong>Comparative kinetic studies<\/strong> \u2014 c\u00f4te \u00e0 c\u00f4te avec <a href=\"https:\/\/medsbase.com\/fr\/cjc-1295-with-dac\/\">CJC-1295 avec DAC<\/a> pour isoler l'effet de l'ancrage \u00e0 l'albumine sur la signalisation de l'axe GH<\/li>\n<li><strong>Comparaisons d'analogues de GHRH<\/strong> \u2014 en parall\u00e8le <a href=\"https:\/\/medsbase.com\/fr\/sermorelin-peptide-guide\/\">sermor\u00e9line<\/a> et <a href=\"https:\/\/medsbase.com\/fr\/tesamorelin-peptide-guide\/\">t\u00e9samor\u00e9line<\/a> for cross-analog pharmacology studies<\/li>\n<\/ul>\n<p>Pour un contexte plus large sur les peptides de l'axe GH, consultez le <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\">catalogue de peptides<\/a>. <\/p>\n<h2>Forces et concentrations disponibles<\/h2>\n<p>MedsBase propose de la CJC-1295 sans DAC dans les tailles de flacons lyophilis\u00e9s suivantes :<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Concentration du flacon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Cas d'utilisation typique<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tailles de conditionnement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dosage pilote, titration ou protocoles courts<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 supports ~50 administrations at 100 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocoles prolong\u00e9s, dosages multiples quotidiens, co\u00fbt au mg le plus bas<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Because Mod GRF 1-29 is typically dosed 2\u20133x daily at 100\u2013200\u00a0mcg per administration, a 5\u00a0mg vial supports 2\u20133 weeks of use. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>Comparaison \u2014 CJC-1295 sans DAC vs avec DAC vs Ipamorelin<\/h2>\n<p>Les trois peptides de l'axe GH diff\u00e8rent significativement par leur r\u00e9cepteur, leur demi-vie et leurs caract\u00e9ristiques de combinaison :<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e8re<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">CJC-1295 sans DAC<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">CJC-1295 avec DAC<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Ipamorelin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Classe<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Analogue de GHRH (demi-vie courte)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Analogue de GHRH (demi-vie prolong\u00e9e)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GHRP (r\u00e9cepteur de la ghr\u00e9line)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Demi-vie<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~30 minutes<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~7 jours (li\u00e9 \u00e0 l'albumine)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~2 heures<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Profil de GH<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pulsatile, physiologique<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u00c9l\u00e9vation soutenue<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pouss\u00e9e pulsatile<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose typique<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100\u2013200 mcg, 2\u20133 fois par jour<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20132 mg par semaine<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">200\u2013300 mcg, 2\u20133 fois par jour<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Ideal use<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pulse-timing studies, same-pulse stacking<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sustained IGF-1 studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Association canonique avec le CJC-1295<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Comparaison compl\u00e8te des protocoles dans notre <a href=\"https:\/\/medsbase.com\/fr\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin + CJC-1295 guide<\/a>. <\/p>\n<h2>Stockage et reconstitution<\/h2>\n<p><strong>Avant la reconstitution :<\/strong> conserver les flacons lyophilis\u00e9s au r\u00e9frig\u00e9rateur entre 2 et 8 \u00b0C dans leur emballage d'origine, stables jusqu'\u00e0 36 mois. \u00c9viter les cycles de cong\u00e9lation-d\u00e9cong\u00e9lation de la poudre. <strong>Proc\u00e9dure de reconstitution :<\/strong> injecter de l'eau bact\u00e9riostatique le long de la paroi du flacon de peptide selon le tableau ci-dessus. Agiter doucement \u2014 ne pas <strong>re\u00e7oit pas<\/strong> secouer \u2014 et laisser 5 \u00e0 10 minutes pour une dissolution compl\u00e8te. La solution doit \u00eatre claire et incolore. <strong>Apr\u00e8s reconstitution :<\/strong> conserver au r\u00e9frig\u00e9rateur \u00e0 2\u20138 \u00b0C et utiliser dans les 30 jours. Ne pas congeler la solution reconstitu\u00e9e. <\/p>\n<h2 id=\"faqs\">Questions fr\u00e9quemment pos\u00e9es<\/h2>\n<h3>What is CJC-1295 without DAC used for in studies?<\/h3>\n<p>CJC-1295 without DAC (Mod GRF 1-29) is used in studies investigating pulsatile growth-hormone release, GHRH-receptor pharmacology, IGF-1 response kinetics, sleep architecture, body composition, and synergistic stacking with GHRP peptides such as ipamorelin. It is <strong>re\u00e7oit pas<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>Quelle est la diff\u00e9rence entre le CJC-1295 avec et sans DAC ?<\/h3>\n<p>Both versions share the same core modified GHRH (1-29) sequence. The &#8220;with DAC&#8221; version has a maleimide group that binds covalently to serum albumin, extending plasma half-life from ~30 minutes to ~7 days. The &#8220;without DAC&#8221; version lacks this tether and retains the short half-life needed for pulsatile-protocols. Choice depends on whether the studies question requires sustained or pulsatile GHRH signaling. <\/p>\n<h3>What is the typical dose?<\/h3>\n<p>Les protocoles pr\u00e9cliniques publi\u00e9s utilisent g\u00e9n\u00e9ralement 100\u2013200 mcg par administration, 2\u20133 fois par jour. Un flacon de 5 mg reconstitu\u00e9 avec 2,0 mL d'eau bact\u00e9riostatique donne une solution \u00e0 2,5 mg\/mL \u2014 4 crans sur une seringue U-100 d\u00e9livrent 100 mcg. <\/p>\n<h3>Le CJC-1295 sans DAC est-il approuv\u00e9 par la FDA ?<\/h3>\n<p>No. Neither the with-DAC nor without-DAC version of CJC-1295 has received FDA, EMA, or any regulatory approval. Original development by ConjuChem was discontinued. All CJC-1295 sold by specialist suppliers is for clinical investigation only. <\/p>\n<h3>Why would I choose &#8220;without DAC&#8221; over &#8220;with DAC&#8221; in studies?<\/h3>\n<p>&#8220;Without DAC&#8221; is preferred when the studies question involves pulsatile physiological GH signaling, same-pulse ipamorelin stacking (both peptides timed together), or sleep-architecture studies where pre-sleep dosing needs to align with the natural nocturnal GH surge. &#8220;With DAC&#8221; is preferred for sustained-IGF-1 elevation studies and simpler weekly dosing. <\/p>\n<h3>Comment conserver le CJC-1295 sans DAC ?<\/h3>\n<p>Flacons lyophilis\u00e9s : r\u00e9frig\u00e9r\u00e9s \u00e0 2\u20138 \u00b0C dans leur emballage d'origine, stables jusqu'\u00e0 36 mois. Solution reconstitu\u00e9e : r\u00e9frig\u00e9r\u00e9e \u00e0 2\u20138 \u00b0C, \u00e0 utiliser dans les 30 jours. Ne pas congeler la solution reconstitu\u00e9e. <\/p>\n<h3>Comment reconstituer le CJC-1295 sans DAC ?<\/h3>\n<p>Suivez le tableau de reconstitution ci-dessus. Ajoutez de l'eau bact\u00e9riostatique le long de la paroi lat\u00e9rale du flacon, agitez doucement et laissez reposer 5 \u00e0 10 minutes pour une dissolution compl\u00e8te. Ne <strong>re\u00e7oit pas<\/strong> secouez pas. <\/p>\n<h3>Dois-je associer le CJC-1295 sans DAC \u00e0 l'ipamor\u00e9line ?<\/h3>\n<p>Yes \u2014 this is the canonical GH-axis stack for pulsatile-signaling studies. Both peptides are typically dosed together 2\u20133x daily; the short half-lives of both align so that each administration produces a same-pulse synergistic GH release. See our <a href=\"https:\/\/medsbase.com\/fr\/ipamorelin-cjc-1295-stack-guide\/\">guide d'association<\/a>. <\/p>\n<h3>Quelles sont les dosages disponibles chez MedsBase ?<\/h3>\n<p>MedsBase carries CJC-1295 without DAC in 2\u00a0mg, 5\u00a0mg, and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis on request. <\/p>\n<h3>Does CJC-1295 without DAC cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a reasonable safety profile at typical doses. The most commonly reported observation is transient injection-site redness. Long-term human safety data are not available. Because the pulsatile kinetics are closer to native GHRH than the DAC version, some users consider this form more physiologically consistent. <\/p>\n<h3>Quelle est la demi-vie du CJC-1295 sans DAC ?<\/h3>\n<p>Le CJC-1295 sans DAC (GRF(1-29) modifi\u00e9) a une demi-vie plasmatique d'environ 30 minutes \u2014 prolong\u00e9e par rapport aux ~7 minutes de la GHRH(1-29) native gr\u00e2ce \u00e0 quatre substitutions d'acides amin\u00e9s qui prot\u00e8gent contre la d\u00e9gradation enzymatique. Cette demi-vie mod\u00e9r\u00e9e produit un mod\u00e8le de lib\u00e9ration pulsatile de GH, le rendant plus physiologiquement similaire \u00e0 la signalisation endog\u00e8ne de la GHRH que la forme \u00e0 DAC \u00e0 action prolong\u00e9e. <\/p>\n<h3>Pourquoi choisir le CJC-1295 sans DAC plut\u00f4t que la version avec DAC ?<\/h3>\n<p>CJC-1295 without DAC preserves a pulsatile GH secretion pattern similar to endogenous GHRH physiology. Study protocols prioritising physiological pulsatility \u2014 particularly when stacking with a GHRP like Ipamorelin \u2014 typically use the no-DAC form. The DAC version is favoured in studies requiring maximal GH area-under-the-curve with less frequent administration. <\/p>\n<h3>Puis-je commander du CJC-1295 sans DAC pour une livraison internationale ?<\/h3>\n<p>Oui. MedsBase exp\u00e9die le CJC-1295 sans DAC dans le monde entier depuis notre r\u00e9seau d\u00e9di\u00e9 \u00e0 l'exp\u00e9dition de peptides. Les commandes contenant uniquement des peptides sont \u00e9ligibles \u00e0 notre service d'exp\u00e9dition d\u00e9di\u00e9. Les envois sont effectu\u00e9s dans un emballage \u00e0 temp\u00e9rature contr\u00f4l\u00e9e avec un suivi complet. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/fr\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/fr\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/fr\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Agoniste s\u00e9lectif de la ghr\u00e9line \u2014 pic d'hormone de croissance propre sans cortisol\/prolactine<\/li>\n<li><a href=\"\/fr\/cjc-1295-with-dac\/\"><strong>CJC-1295 avec DAC<\/strong><\/a> \u2014 Analogue de GHRH avec demi-vie prolong\u00e9e<\/li>\n<li><a href=\"\/fr\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Pour en savoir plus<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lisez notre guide complet bas\u00e9 sur des preuves : <a href=\"https:\/\/medsbase.com\/fr\/ipamorelin-cjc-1295-stack-guide\/\"><strong>Ipamorelin &amp; CJC-1295 \u2014 m\u00e9canisme, combinaison et protocoles<\/strong><\/a>. Couvre la pharmacologie pulsatile vs soutenue du GHRH, les diff\u00e9rences cin\u00e9tiques DAC vs sans DAC, les protocoles de combinaison canoniques, la reconstitution et les notes de s\u00e9curit\u00e9.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Soutient la signalisation de croissance<br \/>\n\u2705 Am\u00e9liore la r\u00e9gulation m\u00e9tabolique<br \/>\n\u2705 Favorise la r\u00e9g\u00e9n\u00e9ration tissulaire<br \/>\n\u2705 Am\u00e9liore les voies de r\u00e9cup\u00e9ration<br \/>\n\u2705 Am\u00e9liore l'\u00e9quilibre hormonal<\/p>\n<p><strong>CJC-1295 avec DAC<\/strong> contient un compos\u00e9 peptidique synth\u00e9tique.<\/p>","protected":false},"featured_media":70945,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5471],"class_list":["post-69005","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-cjc-1295-without-dac","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product\/69005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/comments?post=69005"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media\/70945"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media?parent=69005"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=69005"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=69005"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=69005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}